Analysis of 239 ordinary and severe cases of COVID-19: Clinical features and treatment


Submitted: 31 December 2020
Accepted: 29 April 2021
Published: 1 July 2021
Abstract Views: 1231
PDF: 380
HTML: 2
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Susan Azizmohammadi Hajar Hospital, Aja University of Medical Science, Tehran, Iran, Islamic Republic of.
  • Sima Azizmohammadi Department of Gynecology, Hajar Hospital, AJA University of Medical Sciences, Tehran, Iran, Islamic Republic of.
  • Sarah Dahmardeh Medical Doctor, Tehran, Iran, Islamic Republic of.
  • Hossein Azargashb Hajar Hospital, Aja University of Medical Science, Tehra, Iran, Islamic Republic of.
  • Seyyed Javad Hosseini Shokouh Hajar Hospital, Aja University of Medical Science, Tehran, Iran, Islamic Republic of.
  • Mojgan Mohajeri-Iravani Department of Anesthesiology, Paramedical Faculty, Hajar Hospital, AJA University of Medical Sciences, Tehran, Iran, Islamic Republic of.
  • Maziar Mobasher Hajar Hospital, Aja University of Medical Science, Tehran, Iran, Islamic Republic of.
  • Saeed Soleiman-Meigooni Hajar Hospital, Aja University of Medical Science, Tehran, Iran, Islamic Republic of.
  • Mahdi Zabihi Hajar Hospital, Aja University of Medical Science, Tehran, Iran, Islamic Republic of.

This study retrospectively analyzed the clinical characteristics of patients with new coronavirus infection (COVID-19) and summarizes the treatment experience. A total of 239 COVID-19 patients admitted to the Hajar Hospital, Aja University of Medical Science, Tehran, Iran from March 22, 2020 to May 18, 2020 were selected, including 176 cases in the ordinary group and 63 cases in the severe/critical group. We collected and compared the clinical data of the two groups of patients, including general conditions, clinical symptoms, signs, laboratory tests, lung CT imaging and prognosis, and analyzed the treatment plans of the two groups. The mean age of 239 COVID-19 patients was 48.1±17.6 years, including 132 males. Patients in the severe and critically ill groups were older than the normal group, with more males and more underlying diseases. The difference was statistically significant (p < 0.05). The lymphocyte (LYM) counts and albumin (ALB) counts of the severe and critically ill groups were more significantly lower than those of the normal group; while the percentage of neutrophils (NEU), C-reactive protein (CRP), D-dimer, and lactate The increase of lactate dehydrogenase (LDH) and urea nitrogen (BUN) was more significant, and the difference was statistically significant (p < 0.05). Patients in the severe and critically ill groups received more antiviral drugs, glucocorticoids, and nasal catheters than those in the normal group, and the difference was statistically significant (p < 0.05). Also, we observed that the most radiological finding was bilateral ground-glass opacity in both groups, however, the rate of typical abnormalities in both chest CT scan and chest x-ray was significantly higher in sever/critical group except air-bronchogram. Taken together, we showed that combination of oseltamivir and glucocorticosteroid such as dexamethasone was very effective in severe patients.


Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Potential for global spread of a novel coronavirus from China. J Travel Med. 2020 Mar 13;27(2):taaa011. DOI: https://doi.org/10.1093/jtm/taaa011

National Health Commission of the People's Republic of China. The latest situation of the new coronavirus pneumonia epidemic situation as of 24:00 on February 18. [EB/OL].[2020-02-19]

Shang Y, Pan C, Yang X, Zhong M, Shang X, Wu Z, Yu Z, Zhang W, Zhong Q, Zheng X, Sang L, Jiang L, Zhang J, Xiong W, Liu J, Chen D. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care. 2020 Jun 6;10(1):73. DOI: https://doi.org/10.1186/s13613-020-00689-1

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. Erratum in: JAMA. 2021 Mar 16;325(11):1113. DOI: https://doi.org/10.1001/jama.2020.1585

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514-523. Epub 2020 Jan 24. DOI: https://doi.org/10.1016/S0140-6736(20)30154-9

Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, Jiang YZ, Xiong Y, Li YJ, Li XW, Li H, Fan GH, Gu XY, Xiao Y, Gao H, Xu JY, Yang F, Wang XM, Wu C, Chen L, Liu YW, Liu B, Yang J, Wang XR, Dong J, Li L, Huang CL, Zhao JP, Hu Y, Cheng ZS, Liu LL, Qian ZH, Qin C, Jin Q, Cao B, Wang JW. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020 May 5;133(9):1015-1024. DOI: https://doi.org/10.1097/CM9.0000000000000722

Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr;92(4):418-423. doi: 10.1002/jmv.25681. Epub 2020 Feb 7. Erratum in: J Med Virol. 2020 Oct;92(10):2249. DOI: https://doi.org/10.1002/jmv.25681

Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, Lui SF, Szeto CC, Chung S, Sung JJ. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003 May 15;348(20):1986-94. Epub 2003 Apr 7. DOI: https://doi.org/10.1056/NEJMoa030685

Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla AI, Memish ZA. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013 Sep;13(9):752-61. Epub 2013 Jul 26. DOI: https://doi.org/10.1016/S1473-3099(13)70204-4

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. Epub 2020 Jan 30. DOI: https://doi.org/10.1016/S0140-6736(20)30211-7

de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523-34. Epub 2016 Jun 27. DOI: https://doi.org/10.1038/nrmicro.2016.81

Azizmohammadi, S., Azizmohammadi, S., Dahmardeh, S. ., Hossein Azargashb, Shokouh, S. J. H., Mohajeri-Iravani, M. ., Mobasher, M., Soleiman-Meigooni, S. ., & Zabihi, M. (2021). Analysis of 239 ordinary and severe cases of COVID-19: Clinical features and treatment. European Journal of Translational Myology, 31(3). https://doi.org/10.4081/ejtm.2021.9579

Downloads

Download data is not yet available.

Citations


Similar Articles

You may also start an advanced similarity search for this article.